| Asthma and respiratory diseases | Lifetime | 3 | GB 1 | 99.96 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 11 | GB 3 | 99.90 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 4 | GB 2 | 99.87 |
| Pediatric health and respiratory diseases | Lifetime | 5 | GB 2 | 99.90 |
| Respiratory and Cough-Related Research | Lifetime | 4 | GB 1 | 99.96 |
| IL-33, ST2, and ILC Pathways | Lifetime | 8 | GB 2 | 99.83 |
| Allergic Rhinitis and Sensitization | Lifetime | 58 | GB 9 | 99.63 |
| Pharmacological Effects and Assays | Lifetime | 48 | GB 5 | 98.78 |
| Ion Channels and Receptors | Lifetime | 41 | GB 6 | 99.05 |
| Air Quality and Health Impacts | Lifetime | 323 | GB 22 | 99.15 |
| Neonatal Respiratory Health Research | Lifetime | 446 | GB 46 | 98.75 |
| Respiratory Support and Mechanisms | Lifetime | 408 | GB 42 | 98.87 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 254 | GB 19 | 98.43 |
| Climate Change and Health Impacts | Lifetime | 227 | GB 27 | 98.22 |
| Neuropeptides and Animal Physiology | Lifetime | 414 | GB 35 | 98.51 |
| Medical and Biological Ozone Research | Lifetime | 51 | GB 3 | 97.31 |
| Neuroscience of respiration and sleep | Lifetime | 587 | GB 43 | 97.75 |
| Delphi Technique in Research | Lifetime | 141 | GB 35 | 96.60 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 678 | GB 45 | 96.85 |
| Eosinophilic Esophagitis | Lifetime | 633 | GB 46 | 97.08 |
| Pharmaceutical studies and practices | Lifetime | 600 | GB 68 | 96.10 |
| NF-κB Signaling Pathways | Lifetime | 506 | GB 32 | 95.67 |
| Mast cells and histamine | Lifetime | 520 | GB 32 | 95.33 |
| Urticaria and Related Conditions | Lifetime | 545 | GB 32 | 95.79 |
| Hydrogen's biological and therapeutic effects | Lifetime | 128 | GB 6 | 91.64 |
| Histone Deacetylase Inhibitors Research | Lifetime | 997 | GB 44 | 92.52 |
| Biomarkers in Disease Mechanisms | Lifetime | 791 | GB 30 | 81.47 |
| Inflammation biomarkers and pathways | Lifetime | 566 | GB 15 | 76.88 |
| Asthma and respiratory diseases | 2021-2025 | 19 | GB 7 | 99.71 |
| Respiratory and Cough-Related Research | 2021-2025 | 7 | GB 4 | 99.58 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 10 | GB 3 | 98.79 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 41 | GB 11 | 99.09 |
| Pediatric health and respiratory diseases | 2021-2025 | 28 | GB 11 | 97.93 |
| Air Quality and Health Impacts | 2021-2025 | 536 | GB 18 | 96.51 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 143 | GB 16 | 92.96 |
| Climate Change and Health Impacts | 2021-2025 | 489 | GB 31 | 92.75 |
| Eosinophilic Esophagitis | 2021-2025 | 566 | GB 37 | 88.81 |
| Delphi Technique in Research | 2021-2025 | 553 | GB 150 | 74.06 |
| Ion Channels and Receptors | 2021-2025 | 627 | GB 15 | 60.55 |
| Hydrogen's biological and therapeutic effects | 2021-2025 | 621 | GB 6 | 33.34 |
